Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.
about
MDSC and TGFß are required for facilitation of tumor growth in the lungs of mice exposed to carbon nanotubesEpigenetics in myeloid derived suppressor cells: a sheathed sword towards cancerCpG Oligonucleotides as Cancer Vaccine AdjuvantsTumor-infiltrating dendritic cells in cancer pathogenesisImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerUpdate on the challenges and recent advances in cancer immunotherapyMechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancerMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedMyeloid-derived suppressor cells: the dark knight or the joker in viral infections?Isolation of myeloid-derived suppressor cells subsets from spleens of orthotopic liver cancer-bearing mice by fluorescent-activated and magnetic-activated cell sorting: similarities and differences.Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis.Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltrationReprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine modelPotential therapeutic anti-tumor effect of a Salmonella-based vaccine.Inflammasomes in cancer: a double-edged sword.The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium.Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.Differential innate immune cell signatures and effects regulated by toll-like receptor 4 during murine lung tumor promotion.HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid-derived suppressor cells in mice.The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection.A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma.Triggering co-stimulation directly in melanoma tumor fragments drives CD8(+) tumor-infiltrating lymphocyte expansion with improved effector-memory properties.Special issue on immune responses in tumors and non-transformed inflammatory microenvironments.Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.Targeting Myeloid-Derived Suppressor Cells in Cancer.Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells.Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain.The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.Immune consequences of anti-angiogenic therapyin renal cell carcinoma.Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling.
P2860
Q23909988-854F3A63-A72A-4491-BB8A-5403686405CAQ26741623-F6142F77-56A3-4D31-BD44-861AE5E25518Q26783826-57B1B4A5-43B1-4928-B3E4-FF080D7EB758Q26861633-9E283C25-70D7-4B90-BC4F-5E6F7087CC43Q26996829-185555E3-44C7-4244-A2F0-C87E3BF7B64CQ27014693-7CD72420-6E66-44FA-B1C4-61F67F2B157EQ27024795-1BF7196E-C792-4F71-9EF4-1E225086B77BQ28084627-91012FFC-217B-49B2-85B3-C080B676129EQ30411008-E12F0210-D6CD-4FAB-B1C0-D1FEF245C66FQ34732885-9E024B43-F907-40EC-92FC-C7804FDADAA4Q34733445-A3DC9E4F-6C05-4DC2-8D53-6C9BF47F4473Q35147988-08A427F7-E011-4E06-A33A-3C3E229ECD3CQ35506659-59467676-43DE-43FF-AB7A-E6516B71A6ECQ35595649-CA413A5B-AC3C-4658-8E5E-19BAE5BAAB31Q35799094-A165B602-6F3D-4E14-B0B3-234145B8EB27Q36503123-B48789F4-84B8-4418-BF78-7A3AF2F943F3Q37530067-F0FE98EC-90CB-470C-AB53-A52CA6928DECQ37610512-DFDCA11F-D183-448E-91C3-5B7BCC21D71FQ37651394-2E6898B2-D8FA-4DE7-A777-7F2F7EE8A150Q38299932-1F0943E1-E834-4D63-AC70-958766683453Q38579710-9199A78B-ACDB-4FDA-B1A5-507F2DE3ECE0Q38702891-B4E9A09B-C410-40FD-9C85-BEC46CCD4CDBQ38774994-9D9E434B-5F49-4E67-A7F0-A757F5ED48D9Q38777128-F3A8B08D-2402-46E3-8FB3-64BC97413A64Q38980527-515A3A3F-537B-4E23-B93D-2FD4B75DBB28Q39328588-E56EE8DF-709A-4A4B-A67F-07D16C75BA0BQ39424862-F0E89945-B242-4271-BF09-B49F1AB415F2Q40301456-D076523D-67BB-41F2-8EBA-7BC5CB30D6C5Q40796643-051D5F8B-0EA7-42E0-8D59-67F101031B4AQ41338809-257FC329-5845-4117-A7C6-3F06499B0F86Q41807501-C0CA3550-4E35-4E93-B555-9D9E343BEA7EQ43163810-9126BA4D-90E4-4C6D-B49C-73C716A79779Q47425171-D4925320-6048-4B59-BB3C-1393C0A05A0FQ47765346-285BA813-B768-4E72-9BA8-2FA36647253AQ48175410-47D1E841-ACDF-4AB3-B2F5-5ECDC122A4E3Q49981026-00473159-A0C2-416C-ACE6-A9D019CA3431Q50175409-DA052EC6-364C-4E89-A8E4-14D3C950067DQ52904194-6E273F50-6049-445D-B4C1-FBBE2B364EB1Q54981236-384BF0C5-6832-44A4-A6FB-35CE5A703632Q55308550-0544F393-F918-4781-A32B-F376B0042FBC
P2860
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Myeloid-derived suppressor cel ...... suppression: thick as thieves.
@en
type
label
Myeloid-derived suppressor cel ...... suppression: thick as thieves.
@en
prefLabel
Myeloid-derived suppressor cel ...... suppression: thick as thieves.
@en
P2860
P356
P1433
P1476
Myeloid-derived suppressor cel ...... suppression: thick as thieves.
@en
P2093
Alexandra Sevko
Viktor Umansky
P2860
P356
10.7150/JCA.5047
P577
2012-11-30T00:00:00Z